AN1
Click for more information
0.00% 0.7¢ anagenics limited

Ann: FGF5 Inhibitors Supply Agreement - Additional Information, page-20

  1. Pharmargeddon
    3,152 Posts.
    lightbulb Created with Sketch. 335
    clock Created with Sketch.
    12/06/21
    10:50
    Post #: 53809571
    Ah yes but they haven't invested in and done the hard yards with getting patents and the proof of the FGF5 process like CDY and its shareholders have they.
    Too busy paying their shareholders to notice.
    Last edited by Pharmargeddon: 12/06/21
    CDY Price at posting: 6.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

BRX Sampling in Argentina points the way to a base metals porphyry for Belararox
right-arrow Created with Sketch.
CCO Calmer Co clocks $150K in sales of its kava-based health drinks at Coles
right-arrow Created with Sketch.
RCE Recce Pharma heading closer to full efficacy data for flagship R327
right-arrow Created with Sketch.
BPH BPH Energy reveals high-profile firms included in latest $1M placement
right-arrow Created with Sketch.
BGD Barton kicks off drilling on-site historical Tarcoola gold play
right-arrow Created with Sketch.
TLG Talga ups graphite exploration target as crit minerals stay in focus
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.229M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 616675 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 100000 1
View Market Depth
Last trade - 16.12pm 16/05/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.